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Measuring Rod and Cone Dynamics in
Age-Related Maculopathy
Peter N. Dimitrov,1 Robyn H. Guymer,1 Andrew J. Zele,2,3 Andrew J. Anderson,4 and
Algis J. Vingrys4
PURPOSE. A cathode-ray-tube (CRT) monitor–based technique
was used to isolate clinically significant components of dark
adaptation. The utility of the technique in identifying adapta-
tion abnormalities in eyes with age-related maculopathy (ARM)
is described.
METHODS. A CRT dark adaptometer was developed to assess
cone and rod recovery after photopigment bleach. The follow-
ing measures were obtained: cone recovery rate (Rc; in de-
cades per minute) and absolute threshold (Tfc; log candelas per
square meter), rod recovery rate (Rr; decades per minute), and
rod–cone transition (rod–cone break [RCB], in minutes).
These components were isolated by appropriately selecting
stimulus size, stimulus location, pigment bleach, and test du-
ration and by coupling the CRT with judiciously selected neu-
tral-density (ND) filters. The protocol was developed by using
5 young observers and was tested on 27 subjects with ARM in
the study eye and 22 age-matched control subjects.
RESULTS. The parameters necessary for effective isolation of
cone and early phase rod dark adaptation were a 2.6 ND filter
(for a standard CRT monitor, 0.08–80 cd  m2 luminance
output); a 4° foveated, 200-ms, achromatic spot; 30% pig-
ment bleaching; and a 30-minute test duration. These settings
returned obvious rod and cone recovery curves in control and
ARM eyes that were compatible with conventional test meth-
ods and identified 93% of participants with ARM as having
delayed dynamics in at least one of the parameters. Cone
recovery dynamics were significantly slower in the ARM group
when compared with age-matched control subjects (Rc, 0.99
0.35 vs. 2.63  0.61 decades  min1, P  0.0001). Three of
the 27 eyes with ARM did not achieve RCB during the allowed
duration (30 minutes). The remaining eyes with ARM (n  24)
exhibited a significant delay in rod recovery (Rr, ARM, 0.16 
0.03 vs. controls, 0.22  0.02 decades  min1, P  0.0001)
and the average time to RCB (SD) in the ARM group was
significantly longer than in the control subjects (19.12  5.17
minutes vs. 10.40  2.49 minutes, P  0.0001).
CONCLUSIONS. The CRT dark-adaptation technique described in
this article is an effective test for identifying abnormalities in
cone and rod recovery. Slowed cone and rod recovery and a
delayed RCB were evident in the eyes with ARM. The test
method is potentially useful for clinical intervention trials in
which ARM progression is monitored. (Invest Ophthalmol Vis
Sci. 2008;49:55–65) DOI:10.1167/iovs.06-1048
Dark adaptation is abnormal in eyes with age-related macu-lopathy (ARM).1–3 The altered adaptation manifests as
delayed rod or cone recovery time and/or an abnormal rod–
cone transition (rod-cone break; RCB), as well as an elevated
cone and rod absolute threshold. Documenting such changes
may provide valuable diagnostic and prognostic information
for identifying and monitoring patients with ARM. Currently,
there is no simple technique that can be used to measure dark
adaptation in routine clinical practice. The standard method
for measuring dark adaptation can take longer than 30 minutes
for complete recovery in normal individuals and more than 1
hour in patients with ARM,3 limiting its clinical usefulness. We
developed a simple and reliable technique in which we used
CRT technology that tracks dark adaptation for a limited time,
yet still yields useful clinical outcomes.
CRT displays are powerful and flexible stimulus generators
when calibrated and driven within their operating limits,4,5
and their use is widespread in basic and clinical science.
However, application of the CRT to dark adaptation has certain
restrictions. First, the lowest achromatic luminance of conven-
tional CRT hardware (RGB) is approximately 0.08 cd  m2,
which is some 3 to 4 log units above the normal rod absolute
threshold. Neutral density (ND) filters can be used to reduce
this luminance, however. Second, the entire range of cone and
rod recovery spans some 5 to 6 log units,6 whereas a CRT’s
output is constrained to 3 log units.7 Given that the limited
luminance range of the CRT will not fully define the entire
recovery curve, we overcame this drawback by gradually at-
tenuating the light output of the CRT by using various strength
ND filters to expose the entire range of cone and rod recovery.
We then investigated whether measuring only a section of the
curve could return useful parameters of rod and cone recovery
by judiciously selecting a single ND filter that exposes clinically
important components, such as the late stages of cone recov-
ery, the RCB, and the slope of the second phase of rod adap-
tation.3
Classic analytic methods, such as the Rushton template for
photopigment bleach, have a limited capacity to describe the
entire dark-adaptation process.8 However, we show that com-
bining Rushton’s approach with modern theories of adapta-
tion6 can a isolate clinically valuable dark adaptation parame-
ters in patients with ARM. As the time for dark adaptation
depends on the level of photopigment bleaching,6,9 target size,
and location,10 we optimized these parameters for the detec-
tion of ARM.
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METHODS
The study was stratified as follows: First we determined the test
parameters (density of the ND filter, stimulus size, and the level of
photopigment bleaching). Then, we verified our method by comparing
its outcome to the recovery obtained with a conventional Goldmann-
Weekers adaptometer. Finally, we established the clinical utility of the
method by applying our technique to a sample of participants with
ARM and comparing their outcomes with those of age-matched con-
trols.
Participants
The protocol was developed on a single healthy individual aged 40
years of age. Comparison with the established method to the Gold-
mann-Weekers test was undertaken on five normal observers, aged 26,
35, 36, 39, and 40 years. The clinical utility of the methodology was
tested on 27 subjects with ARM (67.5  5.0 [SD] years of age) and 22
age-matched control subjects (66.8  5.9 [SD] years of age). Written
informed consent was obtained from all individuals, and ethics ap-
proval for this project was provided by the Human Research and Ethics
Committee of the Royal Victorian Eye and Ear Hospital, Melbourne
(RVEEH). The study was conducted in accordance with the Declara-
tion of Helsinki.
All participants had visual acuity assessment with a logMAR chart11
after autorefraction (Humphrey Automatic Refractometer, model 597;
Carl Zeiss Meditec, Inc., San Leandro, CA) with subjective refinement.
Ophthalmoscopy, slit-lamp examination and assessment of ocular mo-
tility were performed, to exclude confounding ocular diseases in the
participants with ARM and any ocular abnormalities in normal subjects.
Lens opacities were graded with the Wilmer Cataract Grading Sys-
tem.12,13 Persons with significant lens opacity (nuclear, 2.0; cortical,
0.25; or posterior subcapsular, 1 mm2) were excluded.
The fundus status was assessed via slit lamp examination with a
78-D lens and digital fundus photography (Canon CR6-45NM Non-
mydriatic Retinal Camera, Canon Inc., Tochigiken, Japan) after pupil
dilatation (0.5% tropicamide and 10% phenylephrine hydrochloride;
Alcon Laboratories, French Forest, NSW, Australia). The digital images
were assessed by a senior grader trained in the Wisconsin method of
grading (5 years’ experience), using image management software
(OptoMize PRO; Digital Healthcare, Cambridge, UK). The level of
early-stage disease (ARM) and late-stage disease (age-related macular
degeneration; AMD) was scored according to the International Classi-
fication and Grading System for Age-Related Maculopathy.14,15
Automated perimetry of the central 10° field was conducted for the
study eye on each participant (model M700 perimeter; Medmont In-
ternational Pty. Ltd., Vermont, Victoria, Australia). Participants with
paracentral scotoma (significant total deviation [P  0.01] in any point
within 10°) were excluded.
To ensure that neither ocular nor systemic hypertension affected
dark adaptation,16,17 intraocular pressure was measured with a Gold-
mann applanation tonometer, and blood pressure was measured with
an automated cuff (Dinamap; Vital Signs Monitor 1846 SX; Critikon
Inc., Tampa, FL). Participants with systolic blood pressure 140 mm
Hg and/or diastolic 90 mm Hg and/or intraocular pressure 21 mm
Hg were excluded.
A standardized interview regarding history and current symptoms
of eye disease, medical history, and medication was conducted to
exclude systemic disease, and/or medication that could compromise
vision, performance, or interpretation of the results.
For the purpose of experimental validity, we excluded people with
glaucoma, diabetes, significant cataract, visual field defects, narrow
anterior chamber angles, fundus changes due to diseases other than
ARM (e.g., vein occlusion or retinal scar), heterotropia, amblyopia,
color vision abnormalities, and uncontrolled systemic hypertension;
those taking medication that might compromise vision; and those with
neurologic diseases, such as Parkinson’s disease, Alzheimer’s disease,
or stroke. All normal participants (5 young subjects in the validation
group and 22 aged control subjects) had no visible fundus disease, and
visual acuity was better than 20/25 (0.1 logMAR)11 in each eye. The
study eye in the ARM group (n  27) had at least one large high-risk
druse (125 m) within the inner macular area (3000 m diameter,
centered on the fovea),14 and visual acuity was better than 20/25 (0.1
logMAR; Table 1). The nonstudy eye status in the ARM group varied
from the presence of intermediate drusen to choroidal neovasculariza-
tion (four cases) and geographic atrophy (one case), and the visual
acuity of those eyes differed accordingly (Table 1).
Apparatus and Stimuli
Stimuli were presented on a calibrated,4 high-resolution CRT monitor
(Accuvue HM-4721-D; Hitachi, Tokyo; Japan) powered by an 8-bit
video card (Nvidia, Santa Clara, CA, hosted by a Macintosh G4 com-
puter; Apple Computer, Cupertino, CA). The CRT’s luminance output
was -corrected4,5 and modified by using standardized ND filters
(Schott AG, Mainz, Germany) mounted in light-tight goggles worn by
the observer. In pilot trials, filters were chosen to expose the entire
range of rod and cone recovery. A single ND filter was then chosen that
could be used to sample a key 3.0 log units of recovery, and this filter
was used in all subsequent testing.
We produced Ganzfeld photopigment bleaching ranging from 3%
to 99%18 with a device constructed in our laboratory comprising a light
tube (200 mm diameter and 1000 mm long) with a translucent dome
positioned inside the tube at the observer’s end and a light source
positioned at the other end with a 450-mm separation between the
front surface of the light source and the back surface of the dome. The
light source was either a photographic flash (Mecablitz 45 CL-4; Metz-
Werke GmbH & Co., Zirndorf, Germany) or a halogen light source (12
V, 50 W; Philips Inc., Sydney, NSW, Australia). All light sources were
calibrated with an integrating photometer (IL1700; International Light
Inc., Newburyport, MA). The purpose for testing the bleaching level
was to determine the minimum amount of bleaching needed to pro-
vide a fast and reliable clinical test result. In the clinical trial the
photographic flash was used to produce a 30% rod bleach (11 ms
duration; 6.48 log scotopic trolands/second) and a 10% cone bleach
(5.66 log photopic trolands/second) with an 8-mm pupil. Throughout
this article, we specify the level of pigment bleaching as the amount of
rhodopsin bleached, unless stated otherwise.
Psychophysical Methods
Thresholds were measured for a 0.2-second, foveal, achromatic
(1931CIE x  0.267, y  0.318) spot of various sizes (1°–6°). Stimuli
were generated in the center of the monitor to avoid variations in
luminance across the CRT.4 Subjects were asked to fixate the center of
the screen indicated by four 0.5° (width)  1° (length) markers (two
vertical and horizontal) offset from the center of the monitor by 4°.
The target appeared centered in the space between the markers.
Fixation accuracy was monitored with an infrared (940 nm) gaze-
tracking video system (ViewPoint EyeTracker; Arrington Research,
Inc., Scottsdale, AZ). If inaccurate fixation was observed, the subject
was verbally reminded to maintain proper fixation. Post hoc analysis
removed responses when fixation errors were 3°. Such deviations
are not uncommon in clinical applications, but have little impact on
psychophysical outcomes in the absence of a scotoma. Removing these
data from our raw responses did not change the parameter estimates,
but did reduce noise.
Recovery was monitored for a maximum of 30 minutes after bleach-
ing, by using a modified Be´ke´sy tracking procedure.19 The stimulus
timing is shown in Figure 1. Each trial was initiated by the appearance
of fixation markers that remained ON for the duration of the trial (1.5
seconds; Fig. 1). After the onset of the fixation markers, a 0.3-second
foreperiod was allowed to achieve fixation before stimulus presenta-
tion, which lasted 0.2 second. A 1.0-second response window was
followed by a 1.0-second interstimulus delay. True trials were ran-
domly interleaved with 50% false-positive (blank) trials. This procedure
generated a spot on average every 3.75 seconds.
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The observers signaled stimulus detection with a response button.
Participants were told that auditory feedback would be provided on
error responses (responses to blank trails). Observers were instructed,
to minimize the occurrence of errors. Correct identifications resulted
in a 3-dB decrease in stimulus luminance, whereas a NO response to
the true trial resulted in a 1-dB increase in luminance. Post hoc analysis
of the average ARM group response profiles showed that recovery was
sampled every 17.5 seconds on average. The luminance of the fixation
markers tracked the threshold, being 1 log unit brighter than the
stimulus level to which the subject last made a correct response, up to
the maximum luminance of the monitor.
Procedure
Observers were tested monocularly after pupil dilation of more than 7
mm diameter. The pupil size was measured and monitored using the
tracking system (EyeTracker; Arrington Research, Inc.). Average (SD)
pupil size on commencement was 7.80  0.71 mm in the ARM group
and 7.70  0.58 mm in control subjects. Variation in pupil size during
the test did not exceed 1 mm.
Testing was performed in a darkened room, with best refraction for
the test distance being fixed in a lens frame in the goggles. Proper
ventilation was provided in the room to avoid the effect of oxygen
deprivation on photoreceptor recovery.20 Participants were exposed
to the Ganzfeld bleach, and adaptation recovery was tracked immedi-
ately after light offset.
Modeling
The dynamics of the cone and rod recovery were modeled (Excel;
Microsoft, Redmond, WA), by using a single exponential decay8,21
separately for the rod and cone components, according to equation 1
(see the Appendix for derivation):
Tt  log10Tf	TiRt  10Tf, (1)
where the threshold T (in log candelas per square meter) is a function
of time (t) after offset of bleaching (in minutes), Ti is the initial
threshold (log candelas per square meter) of the photoreceptor, Tf is
the asymptotic threshold, and R is the rate of decay (in decades per
minute). The variables are assigned to cone and rod mechanisms by
subscripted alphanumeric c and r, respectively (e.g., Tfc). We found
that for our psychophysical data, a single decaying function (equation
1) adequately defined each of the cone and rod components of dark
adaptation. The rod rate of decay (Rr) value in equation 1 represents
the second mechanism described by Lamb21 for rod dark adaptation.
Parameter optimization was achieved by minimizing the merit function
(sum of squares; Solver module of an Excel spreadsheet; Microsoft,
Redmond, WA).
We report the mean  SD for the data and each of the model
parameters, as well as the 95% confidence limit for the aged normal
observers. Parametric (t-test) and nonparametric (Mann-Whitney) tests
were used as appropriate, to compare the dark adaptation parameters
between the ARM group and age-matched control subjects (Rc ARM
versus Rc Controls; Tfc ARM versus Tfc Controls; RCB ARM versus RCB
Controls; Rr ARM versus Rr Controls), with   0.05. Receiver oper-
ating characteristic (ROC) curves were calculated with commercial
statistical software (GraphPad, ver. 4; GraphPad, San Diego, CA). ROC
parameters were compared by a two-tailed z-statistic that allows for
correlation between data sets derived from the same populations.22,23
RESULTS
Test Parameters
Figure 2 shows threshold recovery (log10) in a normal individ-
ual measured with a foveated, 4° target as a function of time (in
minutes) after a 96% pigment bleaching. The unfilled circles
represent full recovery, exposed with progressively larger ND
filters attenuating the brightness of the CRT stimulus. The
progressively shaded gray horizontal bar along the abscissa
indicates the time points of insertion of different filters. During
the first 4.5 minutes, the initial phase of cone recovery was
tracked by attenuating the CRT stimulus with a 1.0-ND filter
(light gray bar). Interposing the 2.6 ND (4.5–23 minutes) ex-
poses clinically important regions of adaptation: the cone pla-
teau, the RCB and the second phase of rod recovery. At 23
minutes, a 3.3-ND filter was needed to expose the third phase
of rod recovery. The best-fitting models to the cone branch
(solid curve) and the rod branch (dashed curve) were esti-
mated by using equation 1. The RCB in this normal participant
was at 10.3 minutes (10 minutes, 18 seconds) and the decay
rate for cones (Rc) was 1.04 decades  min
1 and for rods (Rr)
0.22 decades  min1. The rate-limited recovery of the second
phase of rod recovery6 found in our experiment is similar to
the previously reported 0.23 to 0.24 decades  min1.3,6 Our
results suggest that testing with the single 2.6 ND filter should
expose the clinically useful domains of cone and rod recovery.
The filled diamonds on Figure 2 represent recovery of the
same participant using a single 2.6 ND filter for the entire
duration of dark adaptation (30 minutes). This procedure gave
FIGURE 1. Representation of the
timing of a stimulus trial (A) and a
false-positive (Blank) trial (B) in the
threshold-tracking procedure.
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2 log units of rod recovery. There is reasonable exposure of
the clinically important aspects of cone and rod recovery: the
cone rate constant, the cone plateau, the RCB, and the second
component of rod recovery. Recovery of these components
was similar to that achieved with the serial ND filters (circles;
Fig. 2).
Figure 3 shows the effect that a range of stimulus sizes had
on the dynamics of dark adaptation for foveal thresholds after
a 96% bleaching in a normal individual. Thresholds for the
smallest (1°) target exposed limited rod activity. As target size
increased, a greater proportion of rods were recruited, expos-
ing an earlier and more prominent second phase of rod recov-
ery. The 4° and 6° targets provided adequate definition of the
key components of both rod and cone function in the macular
area. Previous reports (histologic,24 psychophysical,25 and
electrophysiological26) have shown that rods are most vulner-
able in a ring-shaped macular area with the peak of loss being
2° from the fovea. Therefore, we propose adopting a central
4° stimulus (filled symbols; Fig. 3) when testing eyes with ARM.
The effect that each of the six levels of photopigment
bleach (3%–96%) had on the dynamics of dark adaptation are
shown in Figure 4A for a normal individual. As the bleaching
FIGURE 2. Dark-adaptation curves for
a normal subject (40 years of age) ob-
tained after a 96% pigment bleaching
with a foveated, 4° target. (E) Thresh-
olds achieved by progressively in-
creasing the ND filter (bottom hori-
zontal bar: 1.0, 2.6, and 3.3 ND);
() single 2.6 ND filter (top horizon-
tal bar). Solid curve: best-fitting
model to the cone branch; broken
curve: best-fitting model to the rod
branch (equation 1).
FIGURE 3. Foveal dark adaptation
for a normal subject after a 96% pig-
ment bleaching with several target
sizes and the 2.6 ND filter.
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level increased, the rod–cone transition occurred at a progres-
sively later time. The time course of the second phase of rod
recovery, as indicated by the straight solid lines in Figure 4A,
was the same (0.23 decades  min1) in all cases, whereas
recovery from the lowest level of bleach (3%) showed very fast
recovery, being of a different shape from the other levels of
bleaching, consistent with previous reports.6 When the effect
of different levels of bleaching (Fig. 4B) was considered in
terms of the time for rod second-phase recovery to reach a
criterion threshold (horizontal doted line,3 log cd  m2; Fig.
4A), it showed a linear rate-limited relationship for recovery,
except for the 3% bleaching level (Fig. 4B). Similar results were
found in previous reports6,21 that show rate-limited recovery
for bleaching levels above 20%. The rod–cone transition is
considerably longer in ARM cases,3 therefore the smallest pig-
ment bleaching that gives a rate-limited second phase of the
rod recovery would keep test duration to a minimum. Our light
source bleaches 30% of pigment in an eye with a 8-mm pupil
(average pupil size in our ARM group was 7.80  0.71 [SD]
mm). This level of bleaching yielded a fast recovery (30
minutes in normal eyes) and allowed exposure of the clinically
significant cone components as well as the second, rate-limited
component of rod recovery (Figs. 4A, 4B).
Test Validation
To test the comparability of our dark adaptometer with a
conventional technique, we contrasted measurements ob-
tained with a Goldmann-Weekers adaptometer to our CRT
method in five normal observers using the following test pa-
rameters: 2° achromatic stimulus at 10° inferior field and96%
pigment bleach and the CRT luminance output attenuated with
a single 2.6 ND filter. There were no statistically significant
differences found when the average adaptation parameters
(SD) acquired with a Goldmann-Weekers adaptometer
(GWA) were compared with our CRT method for cone recov-
ery (Rc GWA, 1.18  0.19 vs. Rc CRT 1.19  0.19 decades 
min1, P 0.241; Tfc GWA1.61 0.18 vs. Tfc CRT1.55
0.21 log cd  m2, P  0.140), Rod–cone break (RCB GWA
8.49  1.14 vs. RCB CRT 8.75  1.50 minutes, P  0.467) and
the rod second-phase recovery (Rr GWA 0.26  0.01 vs. Rr
CRT 0.28  0.09 decades  min1, P  0.093). The rod third
phase of the recovery was evident only with the GWA test,
although this part of the dark adaptation curve is not clinically
significant in ARM.3 The rod absolute threshold was also not
evident with the CRT method.
Dark Adaptation in People with ARM and
Age-Matched Controls
The previous experiments showed that a Ganzfeld bleaching of
30% coupled with a 4° stimulus and 2.6 ND filter exposed3
log units of cone and rod recovery in normal participants. This
procedure was applied to a group of 27 patients with ARM
(67.5  5.0 years of age) and 22 aged-matched control observ-
ers (66.8  5.9 years of age). The age distributions in the ARM
group and the control subjects were not significantly different
(t47  0.42, P  0.67). Visual acuities were also not signifi-
cantly different between the groups (logMAR  SD: 0.026 
0.078 ARM vs.0.017 0.083 control; t47  1.98, P 0.067).
In the control group (n  22), the average  SD absolute
threshold for cones (Tfc) was 1.98  0.30 log cd  m
2 with
a recovery rate (Rc) of 2.63  0.61 decades  min
1 (Table 2).
The average time to RCB was 10.40  2.49 minutes; and the
average recovery rate for the second phase of rods (Rr) was
0.22 0.02 decades  min1 (Table 2). The time course of dark
adaptation for a representative age-matched control subject is
shown in Figure 5A. Figures 5B–D show a sample of clinical
cases with ARM reflecting a wide variation in recovery. Figure
5B shows an example of an ARM case with slower cone
recovery, elevated cone threshold, and delayed RCB. Figure 5C
is remarkable in that the participant had a very slow rod second
phase. Figure 5D gives an example of a patient with no evi-
dence of a rod-cone break during the 30 minute test.
In the ARM group (n  27), the cone recovery rate on
average SD was significantly slower than the control rate (Rc
ARM, 0.99  0.35 vs. Rc control, 2.63  0.61 decades  min
1,
Mann-Whitney [MW]  10.0, P  0.0001; Fig. 6A, Table 2).
The Tfc was the least affected parameter (Fig. 6B); however,
FIGURE 4. The effect of pigment bleaching fraction on dark adaptation in a normal subject, obtained with a foveated 4° target and a 2.6 ND filter.
(A) Parallel solid lines: rate-limited (0.23 decades  min1) second phase of rod recovery; horizontal dotted line: recovery criterion used to plot
the relationship in the right panel. (B) Relationship between the fraction of pigment bleached and rod second-phase recovery to a threshold
criterion (horizontal dotted line). The rate-limited component of the second phase of rod recovery shows a linear relationship with the fraction
of pigment bleached for fractions above 27%.
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the difference between ARM and control groups was still
statistically significant (Tfc ARM, 1.62  0.38 log cd  m
2 vs.
Tfc control,1.98 0.30 log cd  m
2; t47  3.64, P 0.0007,
Table 2). The average cone absolute thresholds in the 7 ARM
cases (26%) who had abnormal values was 0.8 log units re-
moved from the average threshold in the control group (Tfc
ARM, 1.19  0.11 log cd  m2 vs. Tfc control, 1.98  0.3
log cd  m2, t27  7.40, P  0.0001, Table 2). It is important
to note that an abnormal (higher) cone threshold yields a faster
RCB, therefore reducing the diagnostic power of the RCB.
Comparison of the average RCB  SD in the control (n 
22) and ARM (n  27, including 3 cases with no RCB; 30
minutes) groups showed significant delays in ARM eyes (MW
50.50, P  0.0001). The average time of the RCB in the 24
participants with ARM who exhibited a rod–cone transition
within the 30-minute test duration was significantly delayed
(19.12  5.17 [SD] minutes) when compared with control
subjects (10.40  2.49 minutes, t44  7.18, P  0.0001; Table
2). Rr rate of the second phase was significantly slower in the
ARM (n  24) group than in the control subjects (Rr ARM
0.16  0.03 vs. Rr control 0.22  0.02 decades  min
1, t44 
6.77, P  0.0001; Fig. 6D).
Of all ARM cases (n  27) 93% had at least one recovery
parameter that was abnormal. Only two ARM cases had all
parameters within the 95% confidence band of age-matched
control observers. Cone parameters were abnormal in 22 pa-
tients (81%, Table 2) with all (n  22) recording delayed
recovery rates (Fig. 6A) and 7 (26% of all ARM) showing
abnormal absolute thresholds (Fig. 6B). The rod–cone transi-
tion (RCB) was abnormal in 22 patients (81%; Fig. 6C). Three
of the ARM patients failed to show an RCB within the 30
minutes of testing (e.g., Fig. 5D). Of the 24 remaining, 15
patients (63%; Fig. 6D) had abnormal rod dynamics in the
second phase.
Figure 7 shows the receiver operating characteristic (ROC)
curves for 22 control subjects and 27 patients in the ARM
group. The plot shows test sensitivity for ARM against false
alarm rate (1  specificity) and demonstrates the diagnostic
capacity, expressed as area under the curve (AUC) of the dark
adaptation parameters. The recovery rate for cones yields a
significantly better diagnostic capacity than does cone absolute
threshold (Rc AUC 0.983  0.014 vs. Tfc AUC 0.761  0.069;
z  3.063, P  0.001). The recovery rate for rods and cones
gave similar diagnostic capacity (Rc AUC 0.983  0.014 vs. Rr
AUC 0.924  0.044; z  1.416, P  0.078), and although both
were better than the RCB, the differences were not statistically
significant (Rc AUC 0.983 0.014 vs. RCB AUC 0.904 0.045,
z  1.469, P  0.071; Rr AUC 0.924  0.044 vs. RCB AUC
0.904  0.045, z  0.261, P  0.397). The lack of significant
differences between the latter parameters most likely reflects
TABLE 2. Dark Adaptation Parameters in Age-Matched Control and Age-Related Maculopathy Groups
Age-Matched
Controls
(n22)
Age-Related Maculopathy Group (n  27)
All ARM cases Abnormal Dark Adaptation Parameters
Average SD Average SD n (%) Average SD
Rc (decades  min
1) 2.63 0.61 0.99 0.35 22 (81%) 0.87 0.24
Tfc (log cd  m
2) 1.98 0.30 1.62 0.38 7 (26%) 1.19 0.11
RCB (minutes) 10.40 2.49 19.12* 5.17* 22 (81%) 21.27* 3.25*
Rr (decades  min
1) 0.22 0.02 0.16* 0.03* 15 (63%)* 0.12* 0.06*
* The three participants with ARM who did not have RCB within the 30 minutes of the test duration are not included (ARM, n  24).
FIGURE 5. Dark-adaptation curves for
four clinical participants. (A) Thresh-
olds () and the fitted model (line) for
an age-matched control; (B–D) thresh-
olds () and fitted models (lines) for
three representatives of the ARM
group. Shaded zone: 95% confidence
interval for the RCB for our 22 normal
observers.
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the low experimental power (0.23) for the sample sizes in our
study.27
Given that cone and rod recovery, as well as the RCB, had
the best diagnostic capacity, we applied these parameters to
consider whether high-risk clinical profiles28,29 varied in their
average SD recovery parameters in our ARM group (Table 1).
Study eyes with drusen and no pigment change (D	P; n  9)
were no different from those that had both drusen and pigment
change (D	P	; n  18; Rc D
	P 0.93  0.21 vs. Rc D
	P	
1.02  0.40 decades  min1, P  0.05; Rr D
	P 0.15  0.06
vs. Rr D
	P	 0.14 0.06 decades min1, P 0.05; RCB D	P
18.37 4.79 minutes versus RCB D	P	 19.49 5.46 minutes,
P 0.05). Study eyes with an AMD fellow eye (n 5, Table 1),
showed a nonsignificant trend for slower recovery compared
with cases with bilateral ARM (Rc AMD in the fellow eye, n 
5, 0.98  0.36 vs. Rc ARM in the fellow eye, n  22, 1.05 
0.34 decades  min1, P  0.05; Rr AMD in the fellow eye, n 
5, 0.18  0.03 vs. Rr ARM in the fellow eye, n  22, 0.16 
0.03 decades  min1, P  0.05). The cases with unilateral
AMD also showed a nonsignificant trend for slower RCB. Two
cases (one geographic atrophy, one choroidal neovasculariza-
tion [CNV]) did not show an RCB within the 30 minutes of
testing (Fig. 5D) and the remaining three CNV cases had an
average RCB of 22.86  2.69 minutes compared with the
18.58  5.26 minutes found in cases with bilateral ARM (n 
22, P  0.05). Nevertheless, although there were trends for
slower recovery in these clinical subgroups, the average trend
was not statistically significant. This result is presumably due to
the small sample size of our ARM cohort, and further investi-
gation with larger sample sizes is warranted.
DISCUSSION
CRT technology provides a universally available and uniquely
flexible presentation modality that can be used to display a
variety of static or modulating stimuli, so that a dark-adaptation
test can be combined easily with other tests of visual func-
tion.30 We have detailed how this technology can be used to
measure dark adaptation in a clinical setting. Using this dark-
adaptation method we identify four clinically important param-
eters: the rate of decay of cones, the cone absolute threshold,
the RCB, and the rate of decay of rods.
Documenting visual recovery promises to be an essential
adjunct to other clinical assessments when investigating
ARM.1–3 However, current methods of measuring adaptation
are not readily adaptable to clinical use. The CRT method
described in this article is a simple and effective device for
measuring the dynamics of dark adaptation. We show how a
dynamic range that extends over the limit of the CRT lumi-
nance output can be exposed by using serial and progressively
larger ND filters (Fig. 2). However, we also argue that the
stepped approach of increasing ND filters is not needed to
yield clinically useful outcomes. The single ND filter (2.6 ND;
Figs. 2–5) will isolate 4 log units of range, which provides
useful information about receptoral dynamics, by way of cone
recovery, the RCB, and the second phase of rod recovery.
Careful matching of the CRT luminance and ND filter en-
sures the greatest range of stimulus control for monitoring
recovery. The 2.6 ND filter used in our configuration was
adopted for our CRT monitor that had a minimum luminance
of 0.08 cd  m2. However, different screen luminance will
need different filters to achieve similar outcomes (e.g., a screen
with a minimal background luminance of 0.2 cd  m2 will
need a 3 ND to achieve the same output as our configuration).
Although we developed our method by using a CRT monitor,
the technique can be used with LCD technology. However, the
number and density of ND filters should be varied because of
the brighter output and limited operating range (2 log units,
data not shown) of LCD displays.
Stimulus location and size (foveated, 4°) have been chosen
to span cones and macular rods, which have been reported as
the most vulnerable to ARM damage.24,25 Coupled with the
modified Be´ke´sy tracking procedure,19 our method provides
the high temporal resolution needed for adequate sampling of
both cone and rod recovery dynamics (Figs. 2–5) from the
same retinal region under common test conditions. Overall,
93% of ARM cases had an abnormality in at least one rod or
cone adaptation parameter, despite their good acuity (log-
MAR  SD, 0.026  0.078).
FIGURE 6. Scatter plots of (A) cone
recovery rate, (B) cone final thresh-
old, (C) rod-cone break, and (D) rod
recovery rate. Participants (n  3)
who did not reach the RCB within
the maximum test duration (30 min-
utes) are not presented in (C) and
(D).
62 Dimitrov et al. IOVS, January 2008, Vol. 49, No. 1
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/932947/ on 12/08/2016
Although three phases define rod recovery,21 use of the 2.6
ND filter and 30% bleaching exposed only the second rate-
limiting component of rod adaptation6,31 in most cases (Figs.
2–5). The third phase of rod recovery was found to be of
limited diagnostic value,3 yet a slow second phase of rod
adaptation and delayed RCB have been found to be sensitive
indicators of ARM1,3,25 as well as good signs of practical dis-
ability.32 Although the central 4° retinal region has a modest
rod population, selective rod losses in this location24,25 are
predictive of the development of ARM.33 In our ARM cohort, of
all 27 cases, 81% showed a delayed rod-cone break. Abnormal
rate constants of the second rod phase were found in 63% of all
cases with RCB within the 30 minutes of the test duration (n
24). Furthermore, the rod recovery rate and RCB measured
with our method had a high diagnostic capacity (ROC, area
under the curve, Rr, 0.924  0.044; RCB, 0.904  0.045).
Although the RCB and the second phase of rod adaptation
have been proposed as the best dark adaptation indicators of
ARM,1,3,25 our technique shows that cone recovery also has
high diagnostic value, with high sensitivity and specificity
(ROC, area under the curve, Rc, 0.983  0.014). Of the ARM
group, 81% had delayed cone recovery, which supports earlier
reports on abnormal cone dynamics.2,30
Coupled with our modest level of bleaching, the test time is
restricted to a maximum of 30 minutes, making it suitable for
clinical application. However, when time does not permit
examination of the entire rod and cone recovery, clinically
meaningful data can be obtained in less than 10 minutes (Figs.
2–5), given the high diagnostic capacity of the cone decay
(ROC, area under the curve, 0.983  0.014). The three observ-
ers who failed to show an RCB all had an abnormally delayed
cone recovery and were deemed abnormal on this attribute
alone.
Five participants in our ARM group had end-stage lesions
(four with CNV and one geographic atrophy [GA]) in their
fellow eyes, indicating a higher risk status.28,29 All five cases
showed either no RCB by 30 minutes (n  2; one case with
CNV and one GA), or had considerable delays (20, 22, and 26
minutes) before rod recovery became evident. This finding
may indicate that the degree of delay in rod recovery correlates
with risk of progression to end-stage disease, an issue presently
under investigation.
The cases with all abnormal adaptation parameters (n 
5) had the worst clinical profiles14 in the study eye: large
central drusen, pigment abnormalities, and an average  SD
visual acuity of 0.068  0.054. The single case of GA was
also in this group and had no RCB. The two remaining
subjects who did not have RCB by 30 minutes also had all
parameters abnormal except for cone absolute threshold in
one of them. Participants with all normal parameters (n  2,
visual acuity: 0.06 and 0.1) had only small drusen in the
middle subfield14; however both cases had minor patches of
hyperpigmentation.
Although we were able to measure dark adaptation in all
our participants, our experience with a larger number of
aged patients has shown that some 4% (3/69) of participants
were not able to perform this test reliably due to physical
limitations and/or an inability to follow instructions. We
FIGURE 7. ROC curves for (A) cone
recovery rate, (B) cone final thresh-
old, (C) RCB, and (D) rod recovery
rate.
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have considered the variability of the indices determined by
our technique by retesting a subset of control subjects (n 
16) and patients (n  24) after 16  6.5 (mean  SD) days.
This returned a coefficient of variation for RCB on retest of
32% (controls) and 44% (ARM): 1.5 dB which is similar to
the variability found in the perimetry indicating that our
method has potential as a clinical application for the early
detection of persons with ARM. Also, comparison of our
data with the conventional Goldmann-Weekers adaptometer
for a similar bleaching level and target size showed similar
profiles for recovery. As our logic is based on the linear
relation between the bleaching source and recovery rate
(Fig. 4B) we have calculated that the pupil diameter must
exceed 6.5 mm and any cataract must have an opacity 0.2
on the Wilmer Cataract Grading System12,13 (pupil size and
lens opacity together 0.2 log units) to achieve a level of
bleaching (20%) that yields the rate-limited response for
our time criterion. Otherwise, a brighter bleaching source
would have to be used.
The CRT dark-adaptation technique described in this article
is a simple and effective device that can provide high temporal
resolution assessment of both rod and cone dynamics under
similar conditions. It has the potential to provide functional
measures of ARM progression for monitoring the efficacy of
interventional therapies in clinical trials.
APPENDIX
The formula for threshold recovery has been specified as a
decaying time-dependent exponential by Lamb.21 Pianta and
Kalloniatis8 have shown that the exponential relationship,
when expressed on a linear log scale, can be described by
straight lines. This concept is formalized in Figure 1 and equa-
tions 9a and 9b of their paper. Although the authors implement
the concept to describe three mechanisms of photoreceptor
recovery (early recovery phase, late recovery phase, and abso-
lute threshold or asymptotic constant), we adapted it for our
clinical implementation as a two component recovery: one
specifying the recovery phase after desensitization and the
other specifying the asymptotic constant or absolute threshold
(Fig. A1). This approach has been adapted as follows.
Pianta and Kalloniatis8 show that the initial recovery phase
becomes a straight line on linear log coordinates
Trt  Tf  Ti  Rt (A1)
where Tr(t) represents threshold for the recovery phase in log
units as a function of time, Ti is the initial threshold elevation
in log units relative to absolute threshold (Tf ), and R is the rate
of recovery in decades per minute (this is related to the expo-
nential decay constant , by R   ln (10)).
Since the final threshold (Tf ) is constant, thresholds mea-
sured during dark adaptation can be described by a combina-
tion of the recovery phase and the final asymptotic threshold as
Tt  log10Trt  10Tf (A2)
This equation results in a smooth transition between these
components, giving a threshold elevation of 0.3 log units (i.e.,
a factor of two), where the two components intersect. By
substituting equations A1 and A2 we have the final equation
Tt  log10Tf	TiRt  10Tf (A3)
which is equation 1 in the text.
Figure A1 shows recovery curves for a range of parameters.
Two families of three curves were plotted to demonstrate the
effect that varying one of the parameters has on the curve.
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